Cemia in youngsters,” The American Journal of Epidemiology, vol. 177, no. 11, pp. 1255262, 2013. A. Shankar, J. Xiao, in addition to a. Ducatman, “Perfluorooctanoic acid and cardiovascular illness in US adults,” Archives of Internal Medicine, vol. 172, no. 18, pp. 1397403, 2012. A. Shankar, J. Xiao, plus a. Ducatman, “Perfluoroalkyl chemical compounds and chronic kidney disease in US Adults,” The American Journal of Epidemiology, vol. 174, no. eight, pp. 89300, 2011. D. Melzer, N. Rice, M. H. Depledge, W. E. Henley, and T. S. Galloway, “Association amongst serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Wellness and Nutrition Examination Survey,” Environmental Health Perspectives, vol. 118, no. 5, pp. 68692, 2010. V. Gallo, G. Leonardi, B. Genser et al., “Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers inside a population with elevated PFOA exposure,” Environmental Well being Perspectives, vol. 120, no. five, pp. 65560, 2012. N. Kudo and Y. Kawashima, “Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals,” Journal of Toxicological Sciences, vol. 28, no. 2, pp. 497, 2003. L. Cui, Q.-F. Zhou, C.-Y. Liao, J.-J. Fu, and G.-B. Jiang, “Studies on the toxicological effects of PFOA and PFOS on rats applying histological observation and chemical evaluation,” Archives of Environmental Contamination and Toxicology, vol. 56, no. two, pp. 33849, 2009. L. M. Eldasher, X. Wen, M. S. Small, K. M. Bircsak, L. L. Yacovino, and L. M. Aleksunes, “Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid,” Toxicology, vol. 306, no. four, pp. 10813, 2013. A. G. Abdellatif, V. Preat, H. S. Taper, and M. Roberfroid, “The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator,” Toxicology and Applied Pharmacology, vol. 111, no. three, pp. 53037, 1991. V. SSTR1 Agonist Purity & Documentation Bindhumol, K. C. Chitra, and P. P. Mathur, “Bisphenol A induces reactive oxygen species generation in the liver of male rats,” Toxicology, vol. 188, no. 2-3, pp. 11724, 2003. D. Bagchi, J. Balmoori, M. Bagchi, X. Ye, C. B. Williams, and S. J. Stohs, “Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative pressure and tissue damage in the liver and brain tissues of mice,” Toxicology, vol. 175, no. 1, pp. 732, 2002. A. P. Senft, T. P. Dalton, D. W. Nebert, M. B. Genter, R. J. Hutchinson, and H. G. Shertzer, “Dioxin increases reactive[12]Conflict of InterestsThe authors declare that there is no conflict of interests.[13]AcknowledgmentsThis study was supported by the National All-natural Science Foundation of China (no. 81060056) and Jiangxi Provincial Education Improvement (no. GJJ12083).[14][15]
NIH Public AccessAuthor ManuscriptBiochim TLR7 Antagonist supplier Biophys Acta. Author manuscript; readily available in PMC 2015 January 01.Published in final edited form as: Biochim Biophys Acta. 2014 January ; 1843(1): . doi:10.1016/j.bbamcr.2013.06.027.NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptRegulation of Proteolysis by Human Deubiquitinating EnzymesZiad M. Eletr and Keith D. Wilkinson Department of Biochemistry, Emory University, Atlanta GAAbstractThe post-translational attachment of a single or numerous ubiquitin molecules to a protein generates a variety of targeting signals which are applied in many distinct methods in the cell. Ubiquitination can alter the activity, localization, protein-protein interactions or stability with the targeted protein. Additional, an incredibly significant number.
